| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000026836 |
| Receipt No. | R000030802 |
| Scientific Title | The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2018-2020) |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2021/04/06 (Ver. 12) |
| Basic information | ||
| Public title | The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2018-2020) | |
| Acronym | The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2018-2020) | |
| Scientific Title | The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2018-2020) | |
| Scientific Title:Acronym | The musculoskeletal function survey of HIV-infected middle-aged and elderly hemophilia(2018-2020) | |
| Region |
|
|
| Condition | |||||
| Condition | hemophilia | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | The aim of this study is to survey the motor function of HIV-infected hemophilia by cross-sectional and longitudinal compares. |
| Basic objectives2 | Others |
| Basic objectives -Others | The aim of this study is to survey the musculoskeletal disorders of HIV-infected the middle-aged and elderly hemophilia. It performs a musculoskeletal screening at the time of hemophilia patient advocacy, and the cross-cutting assessment of motor function. By continuing this survey three years, to survey the longitudinal assessment of the motor function. |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | range of motion, muscular strength, grip strength, limbs lap diameter, 10m walking speed,ADL |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | A case hoping for participation in the fitness test and agree to the study use of the result of range of motion, manual muscle test, a grip strength, the 10m walking test, and ADL questions and investigations(but the 10m walk test is not required.) | |||
| Key exclusion criteria | A case with not healing hemorrhagic arthropathy.
A case with joint bleeds. A case with intramuscular bleeding. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | department of rehabilitaition medicine | ||||||
| Zip code | 162-8655 | ||||||
| Address | 1-21-1 toyama shinzyuku-ku,Tokyo | ||||||
| TEL | +81332027181 | ||||||
| jufujita@hosp.ncgm.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center for Global Health and Medicine | ||||||
| Division name | department of rehabilitaition medicine | ||||||
| Zip code | 162-8655 | ||||||
| Address | 1-21-1 toyama shinzyuku-ku,Tokyo | ||||||
| TEL | 0332027181 | ||||||
| Homepage URL | |||||||
| jufujita@hosp.ncgm.go.jp | |||||||
| Sponsor | |
| Institute | National Center for Global Health and Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Foundation for AIDS Prevention |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Center for Global Health and Medicine |
| Address | 1-21-1 toyama shinjuku-ku, Tokyo |
| Tel | 03-3202-7181 |
| rinrijm@hosp.ncgm.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立国際医療研究センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://kyusai.acc.go.jp/aboutus/hemophilia/ResearchReport.html |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://kyusai.acc.go.jp/aboutus/hemophilia/ResearchReport.html | ||||||
| Number of participants that the trial has enrolled | 35 | ||||||
| Results | Muscle weakness has been observed since the 40s. The most significant decrease in muscle strength was hip abduction muscle strength, followed by conspicuous decline in elbow extension strength. The walking speed of the walking speed decreased as the age increased. The range of motion of the joint was most restricted by the extension of the elbow joint, followed by the restriction of the dorsiflexion of the ankle joint. The range of motion was prominent over time in knee flexion and elbow flexion | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Drug damage hemophilia | ||||||
| Participant flow | Among those who gathered at the patient association who participated in the Habaki Welfare Corporation and called for their participation, those who had consent to participate in the study. | ||||||
| Adverse events | nothing | ||||||
| Outcome measures | ROM,MMT,grip,walking speed,ADL | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | study design:cohort
recruitment:Hemophilia Patients' association "Habataki" holds a Gathering of patients every year. At that time, they perform a kind of Measurement event of motor function by our cooperation. In the participants, those who agree to use their data are the subjects of our study. Our study is continued for three years. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030802 |